Study guide
20.2 High-Yield Biochemistry & Molecular Mechanisms
NBME Comprehensive Basic Science Examination CBSE
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Navigation
1.1 Current Exam Facts & Administration 1.2 Content Blueprint & Physician Tasks 1.3 Scoring, Score Reports & Step 1 Readiness
2 Human Development
2.1 Embryology & Congenital Development Patterns 2.2 Normal Age-Related Findings & Well-Patient Care
3 Blood & Hematologic Disease
3.1 Hematopoiesis, RBC Disorders & Anemias 3.2 Hemostasis, Thrombosis & Coagulopathies 3.3 WBC Disorders, Leukemia & Lymphoma Mechanisms
4 Immune System
4.1 Innate & Adaptive Immunity Mechanisms 4.2 Hypersensitivity, Autoimmunity & Immunodeficiency 4.3 Transplant Immunology & Immune Pharmacology
5 Nervous System Anatomy & Disease
5.1 Neuroanatomy Localization & Pathways 5.2 Stroke, Infection, Demyelination & Trauma 5.3 Seizures, Movement Disorders & Neurodegeneration 5.4 Special Senses: Eye & Ear Mechanisms
6 Behavioral Health
6.1 Psychiatric Disorders & Diagnostic Patterns 6.2 Psychopharmacology Mechanisms 6.3 Neurotransmitters, Learning & Behavioral Science
7 Musculoskeletal System
7.1 Bone Physiology, Fracture Healing & Bone Pathology 7.2 Joint Disease, Rheumatology & Connective Tissue 7.3 Muscle, NMJ & Peripheral Nerve Disorders
8 Skin & Soft Tissue
8.1 Dermatopathology High-Yield Lesions 8.2 Inflammation, Wound Healing & Soft-Tissue Infection
9 Cardiovascular Pathophysiology
9.1 Cardiac Cycle, Hemodynamics & Murmurs 9.2 Ischemic Heart Disease & Cardiomyopathy 9.3 Congenital & Valvular Heart Disease 9.4 Vascular Pathology & Hypertension
10 Cardiovascular Pharmacology
10.1 Antihypertensives, Heart Failure & Antiarrhythmics 10.2 Antiplatelets, Anticoagulants & Lipid Drugs
11 Respiratory System
11.1 Pulmonary Mechanics & Gas Exchange 11.2 Obstructive, Restrictive & Vascular Lung Disease 11.3 Pulmonary Infections, Neoplasms & Respiratory Pharmacology
12 Renal Physiology & Electrolytes
12.1 Nephron Transport & Renal Physiology 12.2 Electrolyte Disorders 12.3 Acid-Base Physiology & Compensation
13 Renal Pathology
13.1 Glomerular Disease Mechanisms 13.2 Tubulointerstitial, Vascular & Stone Disease
14 Gastrointestinal System
14.1 GI Physiology, Motility & Digestion 14.2 Esophagus, Stomach & Intestinal Pathology 14.3 Liver, Biliary Tree & Pancreas 14.4 GI Microbiology, Nutrition & Malabsorption
15 Endocrine System
15.1 Hormone Signaling & Hypothalamic-Pituitary Axes 15.2 Thyroid & Parathyroid Disease 15.3 Adrenal Disorders & Steroid Pharmacology 15.4 Diabetes, Glucose Homeostasis & Metabolic Syndrome
16 Reproductive System
16.1 Male & Female Reproductive Physiology 16.2 Pregnancy, Placenta & Developmental Toxicology 16.3 Reproductive Pathology & Hormone-Related Neoplasia
17 Multisystem Processes & Disorders
17.1 Cell Injury, Inflammation & Repair 17.2 Neoplasia Principles & Tumor Biology 17.3 Infection, Sepsis & Multisystem Microbial Disease 17.4 Genetics, Inborn Errors & Environmental Toxicology
18 Biostatistics & Epidemiology
18.1 Study Design, Bias & Causation 18.2 Diagnostic Test Metrics & Screening 18.3 Epidemiology Measures & Population Health
19 Social Sciences & Communication
19.1 Ethics Principles & Decision-Making Capacity 19.2 Communication Skills & Difficult Conversations 19.3 Professionalism, Systems & Practice-Based Learning
20 Integrated Disciplines Capstone
20.1 High-Yield Microbiology Anchors Across Systems 20.2 High-Yield Biochemistry & Molecular Mechanisms 20.3 Integrated Pharmacology Strategy & Exam-Day Execution
20.2 High-Yield Biochemistry & Molecular Mechanisms
Key Takeaways Explain This Topic AI
Glycolysis rate points: hexokinase/glucokinase, PFK-1 (activated by F2,6BP and AMP; inhibited by ATP/citrate), pyruvate kinase; glucagon lowers F2,6BP via PFK-2/FBPase-2 phosphorylation—reciprocal control with gluconeogenesis.
ETC poisons: complex I (rotenone), III (antimycin), IV (CN−, CO, N3−), ATP synthase (oligomycin), uncouplers (2,4-DNP, aspirin overdose) increase O2 consumption while wasting energy as heat; pyruvate dehydrogenase needs B1/B2/B3/B5/lipoic acid.
Inborn errors map substrate accumulation: G6Pase (von Gierke), lysosomal acid maltase (Pompe), debranching (Cori), branching (Andersen), muscle phosphorylase (McArdle), OTC (hyperammonemia + orotic acid, no megaloblasts), orotic aciduria (UMP synthase, megaloblastic anemia).
Collagen synthesis board chain: glycine-X-Y → hydroxylation (Vit C) → glycosylation → triple helix → secretion → cleavage → cross-link (lysyl oxidase, Cu2+); osteogenesis imperfecta (type I collagen), Ehlers-Danlos (type III/V classic), scurvy, Menkes/Wilson copper axis.
Signaling: Gs→↑cAMP, Gi→↓cAMP, Gq→IP3/DAG/Ca2+/PKC; receptor tyrosine kinases (insulin, growth factors); checkpoints G1/S (Rb, p53/p21) and G2/M; apoptosis intrinsic (Bax/Bak, Cyt c, Apaf-1, caspase-9) vs extrinsic (Fas/TNF, caspase-8).
Last updated: August 2026
20.2 High-Yield Biochemistry & Molecular Mechanisms
Quick Answer: Know rate-limiting enzymes , hormonal on/off switches , vitamin cofactors , ETC poison sites , and classic inborn errors as clinical vignettes (hypoglycemia type, tissue affected, lab pattern). Molecular side: second messengers, cell-cycle brakes (Rb/p53), and apoptosis arms (intrinsic vs extrinsic) explain neoplasia and pharmacology stems.
This section consolidates metabolism, structural biochemistry, heme, and cell signaling into exam-ready maps.
Glycolysis Regulation
- Enzyme Role Activators Inhibitors Notes
- Hexokinase Glucose → G6P (most tissues) — G6P Low Km (works at low glucose)
- Glucokinase Same in liver/β cells Insulin (induces) F6P (via regulatory protein) High Km; glucose sensor
- PFK-1 F6P → F1,6BP ( committed ) AMP, F2,6BP ATP, citrate Master glycolytic control
- Pyruvate kinase PEP → pyruvate F1,6BP (feed-forward) ATP, alanine; glucagon via PKA phosphorylation (liver)
Fructose-2,6-bisphosphate bridge: Bifunctional PFK-2/FBPase-2. Fed state (insulin, dephosphorylated): PFK-2 active → ↑F2,6BP → stimulates PFK-1, inhibits FBPase-1 → glycolysis on, gluconeogenesis off. Fasting (glucagon, cAMP/PKA): reverse. This single node explains most “fed vs fasting enzyme activity” stems.
Pyruvate dehydrogenase (PDH) complex: Pyruvate → acetyl-CoA. Cofactors: TPP (B1), FAD (B2), NAD (B3), CoA (B5), lipoic acid . Inhibited by acetyl-CoA, NADH, ATP; activated by dephosphorylation (insulin). Arsenic/lipoic acid inhibition appears in toxicology crossovers. PDH deficiency → lactic acidosis, neurologic issues; treat with ketogenic diet conceptually.
TCA Cycle High-Yield Nodes
- Enzyme Reaction gist Regulation / note
- Citrate synthase Acetyl-CoA + OAA → citrate Inhibited by ATP
- Aconitase Citrate ↔ isocitrate Fluoroacetate/fluorocitrate poison historically
- Isocitrate dehydrogenase → α-KG Major rate limit; ↑ADP/Ca2+; ↓ATP/NADH
- α-KG dehydrogenase → succinyl-CoA Same cofactors as PDH; ↓NADH/succinyl-CoA/ATP
- Succinate dehydrogenase Succinate → fumarate Complex II of ETC; FAD
Anaplerosis: Pyruvate carboxylase (biotin) makes OAA—critical for gluconeogenesis and TCA refill. Acetyl-CoA activates pyruvate carboxylase (links fat oxidation to gluconeogenesis readiness).
Electron Transport Chain & Poisons
- Site Components Inhibitors Effect pattern
- Complex I NADH dehydrogenase Rotenone, piericidin, metformin (mild) ↓ electron flow from NADH
- Complex II Succinate dehydrogenase Malonate (competitive)
- Complex III Cyt b-c1 Antimycin A Blocks after cyt b
- Complex IV Cyt a/a3 (Cu) CN−, CO, N3− , H2S CN/CO: histotoxic hypoxia; cherry-red skin (classic teaching)
- ATP synthase (V) F0F1 Oligomycin ↑ gradient, ↓ ATP, ↓ O2 use
Uncouplers — 2,4-DNP , high-dose aspirin , thermogenin (UCP1 brown fat) O2 consumption ↑, ATP ↓, heat ↑, gradient dissipates
ADP/ATP translocase — Atractyloside
Exam pattern recognition:
Oligomycin: respiration stops because proton re-entry blocked; uncoupler cannot fully rescue ATP.
Uncoupler alone: oxygen use rises, ATP falls, hyperthermia.
CN: complex IV; antidote teaching includes nitrite/thiosulfate/hydroxocobalamin (pharm crossover).
CO: competes with O2 on hemoglobin and binds complex IV.
Oxidative phosphorylation yield (teaching numbers): ~2.5 ATP/NADH, ~1.5 ATP/FADH2 (modern estimates); older 3 and 2 still appear in some stems—follow the question’s convention if given.
Gluconeogenesis, Glycogen, PPP
Gluconeogenesis bypasses (liver/kidney):
- Pyruvate carboxylase (mito, biotin) + PEPCK
- Fructose-1,6-bisphosphatase (opposed by F2,6BP)
- Glucose-6-phosphatase (ER; liver/kidney—not muscle)
Muscle cannot export free glucose (no G6Pase)—key for von Gierke vs McArdle distinctions.
Glycogen enzymes:
Disease Enzyme Tissue Hallmark
von Gierke (I) Glucose-6-phosphatase Liver/kidney Severe fasting hypoglycemia, ↑lactate, ↑urate, ↑lipids, hepatomegaly
Pompe (II) Lysosomal α-1,4-glucosidase All (lysosome) Cardiomegaly, hypotonia (infantile); glycogen in lysosomes
- Cori (III) Debranching enzyme Liver ± muscle Milder hypoglycemia; limit dextrin-like glycogen
- Andersen (IV) Branching enzyme Liver Abnormal glycogen; cirrhosis
McArdle (V) Muscle glycogen phosphorylase Muscle Exercise cramps, myoglobinuria; no rise in lactate with ischemic forearm test classic
Hers (VI) Liver phosphorylase Liver Mild hypoglycemia, hepatomegaly
PPP (HMP shunt): G6PD → NADPH for reductive biosynthesis and glutathione reduction in RBCs. G6PD deficiency → oxidative hemolysis (primaquine, sulfa, dapsone, fava, infection); Heinz bodies, bite cells. Transketolase uses B1 —connects to Wernicke pathology when thiamine low.
Fatty Acid Oxidation & Ketogenesis
- Step Key enzyme / fact
- Activation Fatty acyl-CoA synthetase (cytosol)
Shuttle Carnitine acyltransferase CAT-I (rate limit; malonyl-CoA inhibits—prevents futile cycling in fed state)
β-oxidation Mitochondrial spiral → acetyl-CoA; each cycle FADH2 + NADH
MCAD deficiency Hypoketotic hypoglycemia on fasting; dicarboxylic acids; cannot complete medium-chain oxidation
- Ketogenesis HMG-CoA synthase (mito, rate limit for ketones) → acetoacetate, β-hydroxybutyrate, acetone
- Use Extrahepatic mitochondria (thiophorase); liver cannot use ketones (lacks thiophorase)
Fed vs fasting lipid: Fed—insulin → ↑acetyl-CoA carboxylase → malonyl-CoA → FA synthesis, CAT-I off. Fasting—glucagon/epinephrine → lipolysis (HSL), malonyl-CoA down, β-oxidation and ketones on.
Urea Cycle & Nitrogen
- Enzyme Notes Deficiency pattern
- CPS1 Rate limit; N-acetylglutamate activates Hyperammonemia; no orotic acid ↑
OTC (X-linked) Ornithine + carbamoyl phosphate → citrulline Hyperammonemia + ↑ orotic acid (carbamoyl phosphate spills to pyrimidine path); no megaloblastic anemia
ASS, ASL, arginase Later steps Citrullinemia, argininosuccinic aciduria, argininemia
Hyperammonemia effects: Depletes α-KG (→↓TCA), elevates glutamine; cerebral edema, asterixis teaching in adults. Treat conceptually: limit protein, lactulose (clinical), phenylbutyrate/benzoate nitrogen scavengers (board mentions).
Amino acid carbon skeletons: Glucogenic vs ketogenic (Leu and Lys strictly ketogenic; Ile, Phe, Trp, Tyr both). PKU (phenylalanine hydroxylase or BH4), maple syrup (BCKDH—same cofactors as PDH), alkaptonuria (homogentisate oxidase—dark urine, ochronosis), albinism (tyrosinase), homocystinuria (cystathionine β-synthase—lens ectopia downward vs Marfan upward teaching contrast, thrombosis, marfanoid).
Purine & Pyrimidine Paths
- Disorder Defect Hallmark
- Lesch-Nyhan HGPRT (salvage) Hyperuricemia, self-mutilation, orange sand crystals; ↑de novo purines
- SCID (adenosine deaminase) ADA dATP toxicity to lymphocytes
- Gout Uric acid overload (many causes) Negative birefringent needles; allopurinol inhibits xanthine oxidase
Orotic aciduria UMP synthase Orotic acid crystals, megaloblastic anemia, normal ammonia , growth retardation; uridine treatment
OTC deficiency See urea Orotic acid + hyperammonemia without megaloblasts
De novo purine rate limit: PRPP amidotransferase (inhibited by IMP/AMP/GMP). Pyrimidine rate limit: CPS2 (cytosolic; activated by PRPP, inhibited by UTP).
One-Carbon, Folate, B12
- Process Cofactor Clinical failure
- Thymidylate synthesis (dUMP → dTMP) Methylene-THF; TS enzyme Folate deficiency → megaloblastic anemia
Methionine synthase B12 + methyl-THF B12 def: megaloblastic + neuro (subacute combined degeneration); methyl trap
Homocysteine remethylation B12 / folate / MTHFR ↑Homocysteine
Propionyl-CoA → methylmalonyl-CoA → succinyl-CoA B12 (methylmalonyl-CoA mutase) ↑MMA in B12 def (not pure folate def)
Exam discriminator: Both folate and B12 deficiency → megaloblastic anemia; only B12 → high methylmalonic acid and neurologic disease. Folate traps as methyl-THF when B12 missing.
Collagen Synthesis Defects
Order (memorize sequence):
- Translation of preprocollagen (Gly-X-Y; glycine every third)
- Hydroxylation of Pro/Lys ( vitamin C —scurvy)
- Glycosylation of selected hydroxylysines
- Triple helix formation (disulfide knots in propeptides)
- Secretion
- N/C propeptide cleavage → tropocollagen
Cross-linking by lysyl oxidase ( copper )—Menkes (↓Cu absorption) weak collagen/elastin; Wilson is Cu overload differently
- Disease Defect Clinical
- Scurvy No hydroxylation Bleeding gums, corkscrew hairs, poor wound healing
- Osteogenesis imperfecta Type I collagen (COL1A) Fractures, blue sclerae, hearing loss
- Ehlers-Danlos (vascular) Type III collagen Arterial/organ rupture
- Ehlers-Danlos (classical) Type V often Hyperextensible skin, joints
- Menkes ATP7A Cu transport Kinky hair, hypotonia, arterial tortuosity
- Alport Type IV collagen Nephritis, deafness, ocular
- Goodpasture AutoAb to type IV Lung + kidney
Elastin: cross-links include desmosine; α1-antitrypsin deficiency → unopposed elastase → panacinar emphysema; liver inclusions if misfolded protein retained.
Heme Synthesis & Porphyrias
- Step / disease Enzyme Accumulation / clue
- ALA synthase Rate limit; induced by drugs/barbiturates; inhibited by heme/glucose —
Lead poisoning ALA dehydratase + ferrochelatase ↑ALA, ↑zinc protoporphyrin; basophilic stippling; microcytic anemia
AIP Porphobilinogen deaminase (HMB synthase) Abdominal pain, neuropsych, urine porphobilinogen; no photosensitivity; avoid inducing ALA synthase
- PCT Uroporphyrinogen decarboxylase Photosensitivity, blistering, tea-colored urine; most common
- EPP Ferrochelatase Photosensitivity with protoporphyrin
Acute intermittent porphyria attack triggers: CYP-inducing drugs, fasting, stress—because they induce hepatic ALA synthase.
Second Messengers & Signal Transduction Traps
- Receptor class Pathway Examples
- Gs-coupled ↑AC → ↑cAMP → PKA β1/β2, D1, H2, V2, ACTH, FSH/LH/TSH, glucagon
- Gi-coupled ↓cAMP α2, D2, M2, M4
- Gq-coupled PLC → IP3 + DAG → Ca2+ + PKC α1, M1/M3, H1, V1, angiotensin AT1
- Receptor tyrosine kinase Autophosphorylation → RAS-MAPK / PI3K-Akt Insulin, IGF, EGF, PDGF
- Nonreceptor TK (JAK-STAT) Cytokine receptors EPO, growth hormone, prolactin, cytokines
- Intracellular Transcription Steroids, thyroid, vitamin D, retinoic acid
- cGMP NO → GC; or ANP/BNP membrane GC Smooth muscle relaxation; PDE5 inhibitors raise cGMP
Traps:
Insulin is not G-protein-coupled; it is RTK (with IRS).
Steroid hormones are slow transcription effects (except some nonclassical rapid effects rarely tested).
Nitric oxide is paracrine gas via cGMP , not cAMP.
Cholera permanently activates Gs ; pertussis locks Gi inactive (↑cAMP in both cases—different receptors).
Cell Cycle Checkpoints & Apoptosis
- Guardian Function
- Cyclin D–CDK4/6 G1 progression; phosphorylates Rb
- Rb Binds E2F; hypophosphorylated = brake
- p53 DNA damage → p21 (CDK inhibitor) → arrest; or apoptosis
- p21, p27, p16 CDK inhibitors
- Cyclin B–CDK1 G2/M
- APC/C Anaphase progression
HPV: E7 binds Rb; E6 promotes p53 degradation—unrestrained cycle.
Apoptosis:
Pathway Trigger Key molecules
Intrinsic (mitochondrial) DNA damage, withdrawal of growth factors Bax/Bak (pro), Bcl-2/Bcl-xL (anti); Cyt c + Apaf-1 → apoptosome → caspase-9 → effector 3/6/7
- Extrinsic FasL-Fas, TNF FADD → caspase-8 → effectors
- Execution Cleavage of ICAD, lamins, cytoskeleton DNA laddering; apoptotic bodies
Follicular lymphoma t(14;18) → Bcl-2 overexpression → anti-apoptosis. Many chemotherapies act partly via p53-dependent intrinsic apoptosis—p53 mutant tumors more resistant (conceptual).
Integrated Vignette Patterns
Neonate with hypoglycemia, lactic acidosis, hepatomegaly → von Gierke until proven otherwise on exams.
Exercise intolerance without lactate rise → McArdle .
Boy with self-mutilation and gout → Lesch-Nyhan .
Hyperammonemia + orotic acid, no megaloblasts → OTC .
Orotic acid + megaloblasts, normal NH3 → orotic aciduria .
Blue sclerae + fractures → OI / type I collagen .
Abdominal pain + psychiatric + drugs/fasting → AIP .
Hemolysis after primaquine → G6PD .
Hypoketotic hypoglycemia with fasting → MCAD or carnitine shuttle defects.
Master regulation tables and disease-pattern rows; structures of every intermediate are rarely required if the regulatory logic is solid.